In addition, Wang et al. revealed that hyperglycemia-activated MD2/TLR4 mediated local RAS activation and Ang II production via an MAPK-dependent manner, which strongly supported that blockage of MD2/TLR4 could significantly attenuated DN via reducing renal RAS activation [90]. The gene discussed is AGT; the disease is Hyperglycemia.